We recently published a list of the 11 Worst Performing Stocks in S&P 500 So Far in 2025. In this article, we will take a ...

South African global pharmaceutical giant Aspen Pharmacare has found itself caught in Trump tariff-related market volatility, ...

Valued at a market cap of $9.6 billion, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...

From STAT’s Jason Mast: Moderna said this morning in its earnings report it planned to cut costs by around $1.5 billion by ...

The company recently secured approval for olezarsen in FCS, and looks odds on for a follow-up approval in SHTG. Click here to ...

Donald Trump and RFK have caused mayhem in the US medical research market. It's clearing a path for Aussie drug trial contractor IDT.

We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are ...

What will the Trump administration’s proposed changes to federal science spending mean for biomedical research?